FDA recall record

DERMLITE DL4W, REF: DL4W, Rx Only MD, CE recall — FDA Z-1506-2023

Incorrect labeling; Package labeling contains a different serial number then the serial number on the product labeling.

Class IIclassification
Z-1506-2023official record ID
May 10, 2023report date

Recall record at a glance

Official recordZ-1506-2023
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmDermLite LLC
Report dateMay 10, 2023
Recall initiation dateMar 20, 2023
Quantity32 units
LocationSan Juan Capistrano, CA, United States

Official product description

DERMLITE DL4W, REF: DL4W, Rx Only MD, CE

Why the product was recalled

Incorrect labeling; Package labeling contains a different serial number then the serial number on the product labeling.

Distribution information

Worldwide - US Nationwide distribution in the states of CA, AZ, TX, FL, NE, IA, MO, CO and the countries of Saudi Arabia, Australia, Spain.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Telephone.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.